SNCA and Parkinson disease: Exacerbated α-synuclein pathology (22, 23), accelerated breakdown of the BBB (24), and faster cognitive decline (22) reported in PD patients with APOE ε4 allele may be early evidence of accelerated neurodegeneration seen in our PD patients.